In addition, PD-L1 glycosylation also plays an important role in stabilizing the PD-L1 protein, which subsequently inhibits PD-L1 degradation in cancer stem cells, resulting in reduced T cell activity [25]. The gene discussed is CD274; the disease is cancer.